Scientific Presentations

ARVO 2023 | April 2023

Predictive Value of Preferential Hyperacuity Perimetry in Identifying Patients at High Risk of Conversion to Neovascular AMD

Emily Chew, MD
ARVO 2023 | April 2023

A Tele-Ophthalmology Model for Remote Monitoring of Patients with Age-Related Macular Degeneration

Jennifer Jacobs, MD

View the poster presentation here

Hawaiian Eye and Retina Meeting 2023 | January 2023

Update on Home Monitoring of AMD

Judy E. Kim, MD
Virtual Retina Case Conference Canada (RCCC) 2022 | December 2022

Real World Wins for Artificial Intelligence: Preventing AMD Vision Loss

Anat Loewenstein, MD

The ALOFT Study

Allen Ho, MD


SCANLY Home OCT FDA Intended Use

SCANLY Home OCT has not been approved by FDA for use other than described in the following Intend Use: The Notal Vision Home Optical Coherence Tomography (OCT) System is an Artificial Intelligence (AI)-based Home Use device indicated for visualization of intraretinal and subretinal hypo-reflective spaces in a 10 by 10-degrees area centered on the point of fixation of eyes diagnosed with neovascular age-related macular degeneration (NV-AMD). In addition, it provides segmentation and an estimation of the volume of hypo-reflective spaces. The Notal Home OCT device is intended for imaging at home between regularly scheduled clinic assessments and not intended to be used to make treatment decisions or replace standard-of care regularly scheduled examinations and clinical testing as needed, including in-office imaging and assessments for changes in vision, by an ophthalmologist.

See also Warnings and Precautions.

ForeseeHome FDA Intended Use

ForeseeHome has not been approved by FDA for use other than described in the following Indication for Use: The ForeseeHome is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration as an aid in monitoring progression of disease factors causing metamorphopsia including, but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.

Media enquiries? Reach out to our Media Contact